Saturday, July 16, 2011 11:10:15 PM
There are too many unknowns. however, it seems to me that CSBR will have to make an announcement regarding the Company since the minority interest must be reflected in the next 10-K if the Company is funded. Also, we do not know when the rights for the drug that was being tested was being transferred to the new Company. This must also be diusclosed. I, too, am concerned about the lack of disclosure and that is why i wrote the email to the C.E.O. that an announcement had to be made soon or CSBR runs the risk of current shareholders selling their stock due to a lack of information and assumptions that they are making that may be wrong.
There may be a positive spin on this in that CSBR may increase the number of drugs going through the tumorgraft platform to determine whether the drugs have any eficacy in treating cancers. This may lead to a significant increase in sales of CSBR. Perhaps management wanted to become the Company that tests all of the potential drugs for the Israeli Company.
At this point, there are simply too many unanswered questions for us to make a valid decision as to whether this will turn out to be a positive for CSBR. I specifically asked the C.E.O. to indicate why CSBR shareholders will be better off with this kind of a set-up than they would have been the other way. It could be that CSBR felt that they could not get investors who would invest sufficient funds in CSBR to take the drugs through the testing procedures since they would not get a large enough percentage of the Company for the risk that they would be taking. I suspect that pretty soon there will be full disclosure as to exactly what is going on particularly since I let the "cat out of the bag" by letting management know that we investors are aware of what is going on in Israel with CSBR but do not know the details.
Recent CSBR News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 02:12:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 04:45:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 05:47:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 03:57:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 01:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:08:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 08:11:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:54:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 08:52:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 06:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 04:48:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 07:31:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 02:48:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/13/2023 09:47:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:14:51 PM
- Hasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and More • IH Market News • 12/12/2023 10:50:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 05:00:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 04:59:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 04:58:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 04:57:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 04:57:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:32:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 12:37:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 01:53:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 01:52:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM